SLC5A2 and Sepsis: In recent years, prognosis and risk factors, emerging treatment methods (vacuum assisted closure), and pathogenesis (soft tissue infection, sepsis and sodium-glucose cotransporter 2 inhibitor) have been at the forefront of the FG field and may be a future research direction.